Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.

Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. This represents a minor administrative update to the page's version rather than any change to the study information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedAdded the page revision indicator Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor update to the study record.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the study details page.SummaryDifference0.1%

- Check56 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', indicating enrollment has ceased. New help sections for reading the study record and joining the study were added, while minor formatting and revision notes were updated.SummaryDifference0.4%

- Check63 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a minor site version update. This update is part of the page footer metadata and does not modify the clinical trial details or user-facing content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page’s revision tag has been updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.